Cargando…
Therapeutic strategies for glucose transporter 1 deficiency syndrome
Proper development and function of the mammalian brain is critically dependent on a steady supply of its chief energy source, glucose. Such supply is mediated by the glucose transporter 1 (Glut1) protein. Paucity of the protein stemming from mutations in the associated SLC2A1 gene deprives the brain...
Autores principales: | Tang, Maoxue, Park, Sarah H., De Vivo, Darryl C., Monani, Umrao R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764625/ https://www.ncbi.nlm.nih.gov/pubmed/31464092 http://dx.doi.org/10.1002/acn3.50881 |
Ejemplares similares
-
Glut1 deficiency syndrome: New and emerging insights into a
prototypical brain energy failure disorder
por: Tang, Maoxue, et al.
Publicado: (2021) -
Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein
por: Tang, Maoxue, et al.
Publicado: (2017) -
An early endothelial cell–specific requirement for Glut1 is revealed in Glut1 deficiency syndrome model mice
por: Tang, Maoxue, et al.
Publicado: (2021) -
Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
por: Gollapalli, Kishore, et al.
Publicado: (2021) -
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
por: Logel, Santhi N., et al.
Publicado: (2021)